Films d’emballage à haute barrière pour produits pharmaceutiques – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse du marché et de la taille des films d'emballage à haute barrière pour les produits pharmaceutiques

Les virus et germes dangereux étant de plus en plus courants, les gens du monde entier sont de plus en plus soucieux de leur santé. Les industries pharmaceutiques et médicales ont bénéficié de la tendance à adopter un mode de vie sain et de la préférence croissante des consommateurs pour des produits sûrs et hygiéniques. De plus, pour satisfaire les demandes des consommateurs, les producteurs doivent également respecter strictement les normes ISO, telles que les certifications de gestion de la qualité ISO 9001. Par conséquent, les films d'emballage à haute barrière pour produits pharmaceutiques sont mieux adaptés à l'emballage pharmaceutique, élargissant ainsi le marché dans le monde entier.

Le marché mondial des films d'emballage à haute barrière pour produits pharmaceutiques était évalué à 413,22 millions USD en 2021 et devrait atteindre 653,66 millions USD d'ici 2029, enregistrant un TCAC de 5,90 % au cours de la période de prévision 2022-2029. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe Data Bridge Market Research comprend une analyse approfondie des experts, une analyse des importations/exportations, une analyse des prix, une analyse de la consommation de production, une analyse des brevets et des avancées technologiques.

Portée et segmentation du marché des films d'emballage à haute barrière pour produits pharmaceutiques

Market Definition

High barrier packaging films for pharmaceuticals are the films used across the pharmaceutical sector. The high barrier packaging films limit the impact of mineral oil and UV light while assisting in preventing contact with oxygen, carbon dioxide, or moisture. Food attributes including color, taste, texture, aroma, and flavor are retained by the strong barrier formed by the functional elements employed in the packaging film. High barrier films are essential for giving items the necessary qualities and extending their shelf life.

High Barrier Packaging Films for Pharmaceuticals Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Growth In Demand for Multi-layered Packaging Films

High barrier packaging films have multiple layers that limit the effects of mineral oil and UV light as well as interaction with oxygen, moisture, and other gases like carbon dioxide. This strong barrier, which was built utilizing functional materials, aids in maintaining the integrity of the substances housed therein, such as the quality, including color, taste, texture, aroma, and flavor. It is crucial to give products crucial barrier features including moisture, gas, and fragrance in order for them to maintain their integrity. Products with these necessary qualities are largely provided by high barrier films. High-barrier films are solvent-free and won't react with packaged goods within the pharmaceuticals because of their impermeable co-extruded and robust structure.

• Surge in Need for High Barrier Packaging Films across Pharmaceutical Sector

Pharmaceutical companies have different needs for packaging solutions than other industries, including isolation from the outside environment, high levels of protection, cost effectiveness, and ease of handling. High barrier packaging films are so commonly utilized since they prevent gas exchange across the packaging and regulate the temperature inside the package, both of which contribute to the market's expansion. Plastic is the main packaging material because it shields pharmaceutical products from bacteria, moisture, contamination, oxygen, and odor. Polypropylene material is a good option for high-barrier packaging because of these qualities.

Furthermore, the widespread utilization high barrier packaging films for pharmaceuticals for packaging and the increasing the demand for high-quality pharmaceutical packaging will further propelled the growth rate of high barrier packaging films for pharmaceuticals market. The films’ ability to increase these products' shelf life by protecting them from moisture, light, gases, biological contamination, and mechanical damage will drive market value growth. The utilization of these films in pharmaceutical and healthcare sector are other market growth determinants.

Opportunities

• Development of Innovative Recyclable Films

The market for high barrier packaging films for pharmaceuticals is anticipated to expand over the forecast period as material manufacturers continue to develop new and improved plastic films and additives for packaging manufacturing in response to recyclable concerns and biodegradable innovative packaging solutions. These comprise sealant films, high-barrier and foil replacement films, as well as more readily recyclable and naturally degradable films. Another major trend in the packaging and pouch-making industry is to use less material, either by using thinner films or fewer layers of film. These factors will largely extend profitable opportunities to the market players in the forecast period of 2022 to 2029.

• Burgeoning Demand for Customer Friendly Packaging

Additionally, consumers consider a few important factors before choosing the packaging films. Some of them are sanitation and food safety, durability, convenience of use, shelf life, label information, appearance, and environmental effects. The fiber-based packaging made of recycled and recyclable plastic is more appealing to consumers. Thus, there is a huge opportunity for the market for high barrier packaging films to capitalize on in order to experience considerable growth in the future due to the rising trend and need for consumer-friendly packaging.

Restraints/Challenges

• Vulnerability to Degradation

Plastic films' oxidation mechanisms can alter when exposed to heat. Biodegradable polymers, however, can only be completely broken down under carefully controlled conditions, such as elevated temperatures and pressures, which are absent from the natural environment, such as aquatic and marine ecosystems. Thus, these high barrier packing films are expected to deteriorate and lose their qualities under less than ideal circumstances. The global high barrier packaging films for pharmaceuticals market's growth may be hampered as a result.

• Volatile of Raw Material Prices

The high barrier packaging films for pharmaceuticals are made from raw materials such as aluminum, plastics like polyethylene and polypropylene, and a variety of others. These materials are hazardous to the environment, including water and land, non-biodegradable, difficult to recycle, and non-biodegradable. Therefore, the market is projected to have a restricted growth rate.

• Stringent Regulation Associated with the Packaging

Plastic polymers, such as polyethylene, polypropylene, among others are the primary ingredients of high barrier packaging films. These materials are hazardous to the environment, including water and land, non-biodegradable, difficult to recycle, and non-biodegradable. Governments, regulatory agencies, and environmentalists have been raising awareness of the risks of watching such films. Over 40% of plastic is used in the packaging industry. Numerous nations oppose the use and usage of plastic since it takes a long time for it to degrade. Consequently, these regulations will pose as a challenge over the forecasted timeline.

This high barrier packaging films for pharmaceuticals market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the high barrier packaging films for pharmaceuticals market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on High Barrier Packaging Films for Pharmaceuticals Market

The recent outbreak of coronavirus had a significant influence on the high barrier packaging films for pharmaceuticals market.

During the first phase, COVID-19 affected various manufacturing businesses since it caused workplace closures, supply chain disruptions, and transit limitations. However, a considerable impact was noted on the market for high barrier packaging films for pharmaceuticals. Multiple manufacturing facilities were still in use in the area for the operations and supply chain of high barrier packaging films. Following sanitary and safety precautions in the post-COVID environment, the service providers kept providing high barrier packaging films. Since the COVID-19 outbreak, people have been more concerned about their health, hygiene, and safety. Medicines are life-saving drugs that demand the greatest levels of safety and environmental effect protection. High barrier packaging films strengthen the protection of medications from air, water, light, moisture, chemical, bacteria, and germs. As a result, the market was positively impacted by the outbreak of the coronavirus.

Recent Development

• In May 2021, DuPont Mobility & Materials announced it would invest $5 million in capital and operating resources at its manufacturing plants in Germany and Switzerland in order to enhance production of its high-performance automotive adhesives. The investment will increase capacity to meet the rising demand for cutting-edge mobility options for the electrification of vehicles.
• In August 2020, Raven Industries Inc. has introduced the BioFlex I-series, a new product in its plastic film line. It is used in personal defence equipment (PPE). This latex-free film is used in hospitals and laboratories to prevent hospital acquired infections (HAIs). This product adds to the company's product line.

Global High Barrier Packaging Films for Pharmaceuticals Market Scope

The high barrier packaging films for pharmaceuticals market is segmented on the basis of type, product, material, technology and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Metalized Films
• Clear Films
• Organic Coating Films
• Inorganic Oxide Coating Films

Product

• Cold-Formable Films
• Coextruded Films
• Thermo-Formable Films

Material

• Aluminum
• Plastics

 Technology

• Multi-Layer Film
• Sustainable Barrier Coatings
• Besela Barrier Film
• Others

 Application

• Pouches
• Bags
• Lids
• Shrink Films
• Laminated Tubes
• Others

High Barrier Packaging Films for Pharmaceuticals Market Regional Analysis/Insights

The high barrier packaging films for pharmaceuticals market is analyzed and market size insights and trends are provided by country, type, product, material, technology and application as referenced above.

Français Les pays couverts dans le rapport sur le marché des films d'emballage à haute barrière pour les produits pharmaceutiques sont les États-Unis, le Canada et le Mexique en Amérique du Nord, l'Allemagne, la France, le Royaume-Uni, les Pays-Bas, la Suisse, la Belgique, la Russie, l'Italie, l'Espagne, la Turquie, le reste de l'Europe en Europe, la Chine, le Japon, l'Inde, la Corée du Sud, Singapour, la Malaisie, l'Australie, la Thaïlande, l'Indonésie, les Philippines, le reste de l'Asie-Pacifique (APAC) en Asie-Pacifique (APAC), l'Arabie saoudite, les Émirats arabes unis, l'Afrique du Sud, l'Égypte, Israël, le reste du Moyen-Orient et de l'Afrique (MEA) en tant que partie du Moyen-Orient et de l'Afrique (MEA), le Brésil, l'Argentine et le reste de l'Amérique du Sud en tant que partie de l'Amérique du Sud.

L'Amérique du Nord domine le marché des films d'emballage à haute barrière pour produits pharmaceutiques en termes de part de marché et de chiffre d'affaires et continuera de prospérer sur la période de prévision 2022-2029. La croissance du marché dans cette région est attribuée à la croissance de l'industrie pharmaceutique ainsi qu'à la prévalence de diverses entreprises de fabrication dans la région.

L'Asie-Pacifique, en revanche, devrait afficher une croissance lucrative au cours de la période de prévision 2022-2029, en raison des politiques gouvernementales favorables ainsi que de l'énorme production de médicaments à grande échelle en Inde et en Chine dans la région.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces du porteur, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.   

Analyse du paysage concurrentiel et des parts de marché des films d'emballage à haute barrière pour produits pharmaceutiques

Le paysage concurrentiel du marché des films d'emballage à haute barrière pour les produits pharmaceutiques fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination de l'application. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des films d'emballage à haute barrière pour les produits pharmaceutiques.

Certains des principaux acteurs opérant sur le marché des films d’emballage à haute barrière pour les produits pharmaceutiques sont

• Amcor plc (Suisse)
• Mondi (Royaume-Uni)
• Huhtamaki (Finlande)
• Sealed Air (États-Unis)
• Jindal Poly Films Limited (Inde)
• Toppan Inc., (Japon)
• Kureha Corporation (Japon)
• HPM Global, Inc. (Corée du Sud)
• Flair Flexible Packaging Corporation (États-Unis)
• Constantia Flexibles (Autriche)
• MULTIVAC (Allemagne)
• DuPont (États-Unis)
•  Groupe Wihuri (Finlande)
• BERNHARDT Emballage & Process (France)
• Borealis AG (Autriche)
• Schott (Allemagne)
• Dow (États-Unis)
• Société de produits Sonoco (États-Unis)
• Bemis Company Inc. (États-Unis)
• Groupe Huhtamaki (Finlande)
• Uflex Limited (Inde)

SKU-56073